RxDoctor Payments Data

Ann Marie Byers

Adult Health · Gainesville, GANPI 1295729945

Payments from drug & device makers

$1,811in general payments, 2019–2025

Across 101 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$643
  • UCB, Inc.$164
  • Teva Pharmaceuticals USA, Inc.$112
  • SK Life Science, Inc.$100
  • Argenx US, Inc.$75
  • Novartis$74
  • plus $643 from 15 others

What the payments were for

  • Food & beverage$1,811100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,811 in reported general payments places this provider in the 75th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$37,810
Medicare patients
201
Services billed
1,084

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant68$76,040
QuliptaAtogepant35$38,924
Aimovig AutoinjectorErenumab-Aooe14$18,817
EliquisApixaban24$17,936
NeuproRotigotine11$9,020
Emgality PenGalcanezumab-Gnlm11$7,968
Levetiracetam188$3,892
Memantine Hcl121$2,209
Gabapentin104$1,868
Lacosamide54$1,249
Mirtazapine31$1,126
ClopidogrelClopidogrel Bisulfate169$1,119
Atorvastatin Calcium157$788
Amitriptyline Hcl66$732
Divalproex Sodium ErDivalproex Sodium37$732

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$643$114,964103 claims
PfizerEliquis$72$17,93624 claims
UCB, Inc.Neupro$164$9,02011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 577 adult health providers in Georgia.

Other adult health in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →